Recent developments in the field of obesity treatment have generated a new candidate known as ALLUVI Retatrutide. This compound is a {highlyeffective GLP-1 receptor agonist, formulated to mimic the effects of natural glucagon-like peptide-1. Retatrutide has shown remarkable results in clinical trials, demonstrating significant losses in body weight